Beattie. Symbiosis founder Colin MacKay said: “Our team is immensely proud to be able to make a highly meaningful contribution to the global fight against Covid-19 and the urgent efforts to develop a successful vaccine.“With many years of direct experience manufacturing medicines and vaccines of this nature for clinical trials and commercial markets, we are delighted to be able to leverage our expertise and competitive strengths to accelerate the development of this vaccine for Astrazeneca and to add value to the project.”Symbiosis, established in 2011, employs 100 staff from its Stirling headquarters.
Read more on dailyrecord.co.uk